1.
Med Hypotheses
; 160: 110774, 2022 Mar.
Article
in English
| MEDLINE
| ID: mdl-35095174
ABSTRACT
Diethylcarbamazine, the antiparasitic drug, also possesses anti-inflammatory and immunomodulatory activities. The anti-fibrotic activity of diethylcarbamazine makes it a potential candidate to treat coronavirus disease 2019 (COVID-19)-related pulmonary fibrosis. Experimental and clinical studies should assess this possible effect.
2.
Med Educ Online
; 18: 22585, 2013 Sep 24.
Article
in English
| MEDLINE
| ID: mdl-24067792